Biotech Values

[DewDiligence]

Boston Globe feature on (private) Olivia Therapeutics:

https://www.bostonglobe.com/2022/05/19/business/this-startup-aims-make-contraceptives-that-prolong-fertility-delay-menopause-improve-womens-health/

They think it is possible that drugs based on [anti-müllerian] hormone could act as a sort of anti-aging therapy for the ovaries, which age faster than other organs. “The idea is that with healthy ovaries, women may be able to stay healthy longer, and not suffer the consequences of menopause,” such as increased risk of osteoporosis and cardiovascular disease…

…Existing birth control pills — based on the hormones estrogen and progesterone — prevent ovulation, the final stage in a follicle’s life cycle where an egg is released from the ovary to potentially become fertilized. AMH, in contrast, works much earlier in a follicle’s life cycle, pausing its development and thus preserving the eggs.

…using AMH to help women struggling to conceive with IVF…will be Oviva’s first test of its AMH-based therapies in the clinic.